TNN | Posted May 20, 2023 06:23 PM
Under the terms of the MoU, IIITB and Novo Nordisk GBS will jointly engage in initiatives including research, innovation projects, hackathons, case competitions, guest lectures, education programmes, internships, placements, employee development, branding and corporate social responsibility collaborations. The MoU will be effective from May 19, 2023, for a period of two years.
Debabrata Das, director, of IIIT Bangalore, added, “Our goal is to encourage cross-fertilisation of ideas between academic researchers and technical experts from Novo Nordisk to drive innovation and develop novel solutions for the pharmaceutical industry.”
Besides fostering knowledge sharing between industry and academia, the partnership will also provide students at IIIT Bangalore with opportunities to gain real-world experiences, develop new skills, and build relationships with leading industry professionals.
The latest news, articles, and resources, sent to your inbox weekly.
© Copyright 2024 Bennett Coleman & Co. Ltd. All rights reserved.
Powered By SAS ONE | V2.5
About The Author
More Stories
Anatomy of a Scam
Climate and Environmental Sustainability Within the IETF and IRTF
From Commitments to Practice: Internet Society’s Priorities for WSIS+20 Implementation